Sanofi's COVID vaccine trial ends early – what we know
NCT ID NCT04904549
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This Phase 3 study tested two Sanofi COVID-19 vaccines (one targeting the original virus, another targeting two variants) in about 24,000 adults. The goal was to see if they could prevent COVID-19 safely. The trial was terminated early, so final results are limited, but the data may still help improve future vaccines.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
SARS-CoV-2 adjuvanted recombinant protein vaccine (monovalent and bivalent)
What this could lead to
If successful, this could provide a new option for COVID-19 vaccination, potentially offering protection against multiple variants.
What could go wrong
The trial was terminated early, so data may be incomplete. As a Phase 3 study, it was large but results may not apply to newer variants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AES - DRS - Simon Williamson Clinic, PC - Birmingham- Site Number : 8400004
Birmingham, Alabama, 35211, United States
-
AES Austin- Site Number : 8400003
Austin, Texas, 78744, United States
-
AES Salt Lake City- Site Number : 8400016
Murray, Utah, 84123, United States
-
AES St. Petersburg- Site Number : 8400017
Pinellas Park, Florida, 33781, United States
-
American Indian Clinical Trials Research Network Site Number : 8400025
Rapid City, South Dakota, 57701, United States
-
Coastal Carolina Research Center - N Charleston- Site Number : 8400022
North Charleston, South Carolina, 29405, United States
-
Investigational Site Number : 1700001
Bogotá, 111611, Colombia
-
Investigational Site Number : 1700002
Barranquilla, 080020, Colombia
-
Investigational Site Number : 1700003
Soledad, 083001, Colombia
-
Investigational Site Number : 1700004
Floridablanca, 681004, Colombia
-
Investigational Site Number : 1700005
Cali, 76001, Colombia
-
Investigational Site Number : 1700006
Chía, 0000, Colombia
-
Investigational Site Number : 1700007
Girardot, 252431, Colombia
-
Investigational Site Number : 1700008
Barranquilla, 080020, Colombia
-
Investigational Site Number : 1700009
Meta, 0000, Colombia
-
Investigational Site Number : 1700010
Aguazul, 856018, Colombia
-
Investigational Site Number : 1700015
Quindío, 630001, Colombia
-
Investigational Site Number : 2880001
Navrongo, 114, Ghana
-
Investigational Site Number : 2880002
Kintampo, P. O. Box 200, Ghana
-
Investigational Site Number : 2880003
Kumasi, 00000, Ghana
-
Investigational Site Number : 3400001
Municipio Del Distrito Central, 11101, Honduras
-
Investigational Site Number : 3400002
San Pedro Sula, 21104, Honduras
-
Investigational Site Number : 3560001
Jaipur, 302039, India
-
Investigational Site Number : 3560002
Ambawadi, 380015, India
-
Investigational Site Number : 3560003
Punjagutta, 500082, India
-
Investigational Site Number : 3560004
Patna, 801507, India
-
Investigational Site Number : 3560005
Kanpur, 208002, India
-
Investigational Site Number : 3560006
Tamilnadu, 603203, India
-
Investigational Site Number : 3560007
Belagavi, 590002, India
-
Investigational Site Number : 3560009
Nagpur, 440001, India
-
Investigational Site Number : 3560010
Ajmer, 305001, India
-
Investigational Site Number : 3560011
Odisha, 751003, India
-
Investigational Site Number : 3920001
Kyobashi Chuo-ku, Tokyo, 104-0031, Japan
-
Investigational Site Number : 3920002
Ohta-ku, Tokyo, 143-0015, Japan
-
Investigational Site Number : 3920003
Kouenji minami,Suginami-ku, Tokyo, 166-0003, Japan
-
Investigational Site Number : 3920004
Haramachi,Shinjuku-ku, Tokyo, 162-0053, Japan
-
Investigational Site Number : 3920005
Chiyoda-ku,, Tokyo, 101-0041, Japan
-
Investigational Site Number : 4040001
Nairobi, 00100GPO, Kenya
-
Investigational Site Number : 4040002
Kisumu, 40100, Kenya
-
Investigational Site Number : 4040003
Kisumu, 40100, Kenya
-
Investigational Site Number : 4040004
Kericho, 00200, Kenya
-
Investigational Site Number : 4040006
Eldoret, 30100, Kenya
-
Investigational Site Number : 4040007
Nairobi, 00100, Kenya
-
Investigational Site Number : 4040008
Mombasa, 80107 Ganjoni, Kenya
-
Investigational Site Number : 4040009
Thika, 00202 Kiambu, Kenya
-
Investigational Site Number : 4040011
Butere, 50101, Kenya
-
Investigational Site Number : 4040012
Kisumu, 40123 Kisumu, Kenya
-
Investigational Site Number : 4840002
Veracruz, 91910, Mexico
-
Investigational Site Number : 4840003
Guadalajara, Jalisco, 44280, Mexico
-
Investigational Site Number : 4840004
Acapulco de Juárez, Guerrero, 39670, Mexico
-
Investigational Site Number : 4840005
León, Guanajuato, 37000, Mexico
-
Investigational Site Number : 4840006
Temixco, 62587, Mexico
-
Investigational Site Number : 4840008
Cuernavaca, Morelos, 62290, Mexico
-
Investigational Site Number : 4840009
Mexico City, Mexico City, 04530, Mexico
-
Investigational Site Number : 5240001
Nepalgunj, 21900, Nepal
-
Investigational Site Number : 5240002
Dhulikhel, 45200, Nepal
-
Investigational Site Number : 5240003
Kathmandu, 44600, Nepal
-
Investigational Site Number : 8000001
Kampala, 0, Uganda
-
Investigational Site Number : 8000002
Entebbe, 0, Uganda
-
Investigational Site Number : 8000003
Kampala, 42 Nakasero Road, Uganda
-
Investigational Site Number : 8000004
Kampala, Plot 101, Lubowa, Uganda
-
Investigational Site Number : 8000005
Entebbe, 0, Uganda
-
Investigational Site Number : 8000007
Kampala, 23491, Uganda
-
Investigational Site Number : 8000013
Kampala, 10101, Uganda
-
Investigational Site Number : 8000014
Lira, 10101, Uganda
-
Investigational Site Number : 8040001
Kyiv, 03037, Ukraine
-
Investigational Site Number : 8040002
Kiev, 04210, Ukraine
-
Investigational Site Number : 8040003
Kyiv, 02002, Ukraine
-
Investigational Site Number : 8040004
Kyiv, 01023, Ukraine
-
Optimal Research Alabama- Site Number : 8400019
Huntsville, Alabama, 35802, United States
-
Optimal Research, LLC-Melbourne- Site Number : 8400002
Melbourne, Florida, 32934, United States
-
Peninsula Research Associates, Inc.- Site Number : 8400021
Rolling Hills Estates, California, 90274, United States
-
Rochester Clinical Research, Inc.- Site Number : 8400023
Rochester, New York, 14609, United States
-
Synexus Akron- Site Number : 8400009
Akron, Ohio, 44311, United States
-
Synexus Clinical Research Anderson- Site Number : 8400007
Anderson, South Carolina, 29621, United States
-
Synexus Clinical Research Chicago- Site Number : 8400012
Chicago, Illinois, 60602, United States
-
Synexus Clinical Research Evansville- Site Number : 8400008
Evansville, Indiana, 47714, United States
-
Synexus Clinical Research US, Inc. - Atlanta- Site Number : 8400005
Atlanta, Georgia, 30328, United States
-
Synexus Clinical Research US, Inc. - Cincinnati- Site Number : 8400010
Cincinnati, Ohio, 45236, United States
-
Synexus Clinical Research US, Inc. - Henderson- Site Number : 8400018
Henderson, Nevada, 89052, United States
-
Synexus Clinical Research US, Inc. - Orlando- Site Number : 8400020
Orlando, Florida, 32806, United States
-
Synexus Clinical Research US, Inc. - San Antonio- Site Number : 8400015
San Antonio, Texas, 78229, United States
-
Synexus Clinical Research US, Inc. Site Number : 8400013
Centennial, Colorado, 80112, United States
-
Synexus Dallas- Site Number : 8400014
Dallas, Texas, 75231, United States
-
Synexus St. Louis- Site Number : 8400006
St Louis, Missouri, 63141, United States
-
Synexus US Columbus- Site Number : 8400011
Columbus, Ohio, 43212, United States